These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 216831
21. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC). Liu MT, Yeh CY. Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898 [Abstract] [Full Text] [Related]
22. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology. Faggioni A, Corradini C, Venanzoni M, Cardi G, Bevere F, Barile G, Zompetta C, Frati L. J Exp Pathol; 1987; 3(4):471-7. PubMed ID: 2842480 [Abstract] [Full Text] [Related]
23. [The purification and application of Epstein-Barr virus gp125]. Wang G, Pi G, Gu S. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):143-6. PubMed ID: 12515193 [Abstract] [Full Text] [Related]
26. [Evaluation of IgG and IgA type antibodies to capsid and early antigens of the Epstein-Barr virus in the diagnosis of nasopharyngeal carcinoma]. Mendoza J, Rojas A, de la Rosa M, Amador JM, Expósito J, Esquivias J. Med Clin (Barc); 1991 Nov 09; 97(16):609-11. PubMed ID: 1662737 [Abstract] [Full Text] [Related]
29. Serological and immunohistological assessment of Epstein-Barr virus infection in Sicilian patients with suspected nasopharyngeal carcinoma. Ammatuna P, de Thè G, Speciale R, Sammartano F, Arista S, Zerillo G. Microbiologica; 1988 Apr 09; 11(2):89-94. PubMed ID: 2841559 [Abstract] [Full Text] [Related]
30. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma. Shao JY, Huang XM, Yu XJ, Huang LX, Wu QL, Xia JC, Wang HY, Feng QS, Ren ZF, Ernberg I, Hu LF, Zeng YX. Anticancer Res; 2001 Apr 09; 21(4B):3021-9. PubMed ID: 11712805 [Abstract] [Full Text] [Related]
31. Sero-epidemiologic study of the Epstein--Barr virus infectivity in a healthy Cuban population. Gurtsevich V, Le Riverend E, Ruíz R. Neoplasma; 1979 Apr 09; 26(6):677-83. PubMed ID: 232252 [Abstract] [Full Text] [Related]
32. Cytomegalovirus isolations from cell cultures derived from Epstein-Barr virus-associated nasopharyngeal carcinoma. Desgranges C, Seigneurin JM, Baccard M, Nejmi S. J Natl Cancer Inst; 1983 Jul 09; 71(1):39-43. PubMed ID: 6306325 [Abstract] [Full Text] [Related]
38. Antibody to Epstein-Barr virus specific DNase in sera of nasopharyngeal carcinoma and other nine most common cancer patients in Taiwan. Hsu MM, Chen JY, Liu MY, Lynn TC, Tu SM, Yang CS. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Aug 09; 17(3):131-7. PubMed ID: 6096088 [Abstract] [Full Text] [Related]
39. Anti-Epstein-Barr virus antibody in patients with cancer of various sites and control groups. Lin TM, Yang CS, Chiou JF, Tu SM, Hsu MM, Liu CH, Chen KP, Ito Y, Kawamura A, Hirayama T. Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Jun 09; 8(2):93-8. PubMed ID: 173499 [Abstract] [Full Text] [Related]
40. [Antibodies against the Epstein-Barr virus, capsid antigen in children with malignant neoplasms (author's transl)]. Lubec G, Krepler P. Padiatr Padol; 1976 Jun 09; 11(1):88-93. PubMed ID: 175342 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]